Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients.
Antibiotic-associated Clostridium difficile diarrhoea may complicate recovery from surgery for proximal femoral fracture. We undertook a four-year case-control study to evaluate a change in antibiotic prophylaxis in our department. During the period January 2003 to January 2005, patients received three doses of prophylactic cefuroxime (1.5g). We then introduced a new regimen, comprising of one single dose of cefuroxime (1.5g) with gentamicin (240mg) at induction. Prior to the change in prophylaxis, 912 patients underwent surgery for neck of femur fracture, and from March 2005 to March 2007, 899 patients had surgery under the new regimen. Thirty-eight patients developed C. difficile infection (4.2%) in the initial group, compared with 14 patients (1.6%) in the group with the new regimen (P=0.009). The incidence of C. difficile infection increased throughout the rest of the hospital over the same time period. Patients with C. difficile infection had a statistically significant increase in antibiotic exposure, inpatient stay, morbidity and inpatient mortality. The main challenges regarding prophylactic antibiotic selection are infection due to meticillin-resistant Staphylococcus aureus (MRSA) and C. difficile-associated diarrhoea. We advocate the use of the new regimen as an alternative to multiple-dose cephalosporin antibiotics for the prevention of C. difficile infection in this group of high-risk patients.
Starks
I
I
University Hospital North Staffordshire, Stoke on Trent, Staffordshire, UK. ianstarks@doctors.org.uk
Ayub
G
G
Walley
G
G
Orendi
J
J
Roberts
P
P
Maffulli
N
N
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019072:Antibiotic Prophylaxis / Q000379:methods*; D016022:Case-Control Studies; D002444:Cefuroxime / Q000008:administration & dosage*; D016360:Clostridioides difficile / Q000187:drug effects*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D004761:Enterocolitis, Pseudomembranous / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage*; D006620:Hip Fractures / Q000150:complications*; D006801:Humans; D015994:Incidence; D008297:Male
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002444:Cefuroxime